Long-term outcome of chronic hepatitis B in Caucasian patients: Mortality after 25 years

Gut

Volumn 57, Issue 1, 2008, Pages 84-90

  Fattovich, G ^a   Olivari, N ^a   Pasino, M ^a   D'Onofrio, M ^a   Martone, E ^a   Donato, F ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B(E) ANTIGEN; INTERFERON;

ARTICLE; BIOCHEMISTRY; CAUCASIAN; CLINICAL EXAMINATION; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE CARRIER; FEMALE; FOLLOW UP; HAZARD RATIO; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; REMISSION; RISK FACTOR; SEROCONVERSION; SEX DIFFERENCE; SURVIVAL; TREATMENT OUTCOME; ULTRASOUND; VIROLOGY;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; EPIDEMIOLOGIC METHODS; FEMALE; HEPATITIS B, CHRONIC; HUMANS; ITALY; MALE; MIDDLE AGED; PROGNOSIS;

EID: 38349108753     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2007.128496     Document Type: Article

References (29)

1. Lok ASF, McMahon BJ. Chronic hepatitis B. Hepatology 2007;45:507-39.
2. EASL International Consensus Conference on Hepatitis B. Consensus statement. J Hepatol 2003;38:533-40.
3. Beasley RP, Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988;61:1942-56.
4. Lesmana LA, Leung NWY, Mahachai V, et al. Hepatitis B: overview of the burden of disease in the Asia-Pacific region. Liver International 2006;26(Suppl 2):3-10.
5. De Jongh FE, Janssen HLA, De Man RA, et al. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. Gastroenterology 1992;103:1630-5.
6. Realdi G, Fattovich G, Hadziyannis S, et al. Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. J Hepatol 1994;21:656-66.
7. Fattovich G, Giustina G, Realdi G, et al. Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfa. Hepatology 1997;26:1338-42.
8. Fattovich G, Rugge M, Brollo L, et al. Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B. Hepatology 1986;6:167-72.
9. D'Onofrio M, Martone E, Brunelli S, et al. Accuracy of ultrasound in the detection of liver fibrosis in chronic viral hepatitis. Radiol Med 2005;110:341-8.
10. Gaiani S, Gramantieri L, Venturoli N, et al. What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy. J Hepatol 1997;27:979-85.
11. Fattovich G, Ribero ML, Pantalena M, et al. Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centers in Europe. J Viral Hepatitis 2001;8:206-16.
12. Anonymous. Acute and chronic hepatitis revisited. Review by an international group. Lancet 1977;2:914-19.
13. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991;13:372-4.
14. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-81.
15. Peto R, Pike MC. Conservatism of the approximation (0-E)/E in the logrank test for survival data on tumor incidence data. Biometrics 1973;29:579-84.
16. Selvin S. Statistical analysis of epidemiologic data. 3rd edn. New York: Oxford University Press, 2004.
17. Realdi G, Alberti A, Rugge M, et al. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology 1980;79:195-9.
18. Hoofnagle JH, Dusheiko GM, Seef LB, et al. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med 1981;94:744-8.
19. Chen G, Lin W, Shen F, et al. Past HBV load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study. Am J Gastroenterol 2006;101:1-7
20. Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006;295:65-73.
21. Iloeje UH, Yang HI, Jen CL, et al. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006;130:678-86.
22. Keeffe EB, Dieterich DT, Han SHB, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol Hepatol 2006;4:936- 62.
23. Bortolotti F, Guido M, Bartolacci S, et al. Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study. Hepatology 2006;43:556-62.
24. Wong DKH, Cheung AM, O'Rourke K, et al. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med 1993;119:312- 23.
25. Manno M, Cammà C, Schepis F, et al. Natural history of chronic HBV carriers in Northern Italy: morbidity and mortality after 30 years. Gastroenterology 2004;127:756-63.
26. De Franchis R, Meucci G, Vecchi M, et al. The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med 1993;118:191-4.
27. Hsu YS, Chien RN, Yeh CT, et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 2002;35:1522-7.
28. Raimondo G, Brunetto MR, Pontisso P, et al. Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus coinfected patients. Hepatology 2006;43:100-7.
29. Donato F, Gelatti U, Limina RM, et al. Southern Europe as an example of interaction between various environmental factors: a systematic review of the epidemiological evidence. Oncogene 2006;25:3756-70.